Personal identification

Full name

Ana Rita Marçal Dantas de Lima

Citation names

• Ana Rita Lima

Author identifiers

Ciência ID

0C12-8B78-6513

ORCID iD

0000-0001-7429-3617

Telephones

Mobile phone

• 918706623 (Professional)

Knowledge fields

• Medical and Health Sciences - Clinical Medicine - Oncology

Languages

Language	Speaking	Reading	Writing	Listening	Peer-review
Portuguese (Mother tongue)
English	Proficiency (C2)	Proficiency (C2)	Proficiency (C2)	Proficiency (C2)	Proficiency (C2)
French	Advanced (C1)	Advanced (C1)	Advanced (C1)	Advanced (C1)	Advanced (C1)

	Degree	Classification
2014/10/24 - 2021/04/15 Concluded	Medicina e Oncologia Molecular (Curso de doutoramento (conclusão de unidades curriculares)) Major in Cancer Signaling and Metabolism Universidade do Porto Faculdade de Medicina, Portugal
1999/06 Concluded	Medicina (Mestrado) Universidade de Lisboa Faculdade de Medicina, Portugal

Science

	Category Host institution	Employer
2015/10/24 - 2021/04/15	Researcher (Research)	Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
	Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Other Careers

	Category Host institution	Employer
2007/12/01 - 2017/01/30	Carreiras / Categorias Subsistentes	AstraZeneca AB, Sweden
	AstraZeneca AB, Sweden
2002/01/01 - 2007/12/01	Interno (Médica)	Hospital de Egas Moniz, Portugal
2000/01/01 - 2001/12/31	Interno (Médica)	Hospital Distrital de Cascais, Portugal
	Hospital Distrital de Cascais, Portugal

Positions / Appointments

	Category Host institution	Employer
2017/04/01 - Current	Global Study Physician	AstraZeneca R&D Gaithersburg, United States

Publications

Journal article

Sule Canberk; Marcelo Correia; Ana Rita Lima; Massimo Bongiovanni; Manuel Sobrinho-Simões; Paula Soares; Valdemar Máximo. "The Multifaceted Profile of Thyroid Disease in the Background of DICER1 Germline and Somatic Mutations: Then, Now and Future Perspectives". Journal of Molecular Pathology (2022): https://doi.org/10.3390/jmp3010001. 10.3390/jmp3010001 Correia, Marcelo; Lima, Ana Rita; Batista, Rui; Máximo, Valdemar; Sobrinho-Simões, Manuel. "Inherited Thyroid Tumors With Oncocytic Change". Frontiers in Endocrinology 12 (2021): http://dx.doi.org/10.3389/fendo.2021.691979. 10.3389/fendo.2021.691979 Canberk, Sule; Lima, Ana Rita; Pinto, Mafalda; Soares, Paula; Máximo, Valdemar. "Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application". Frontiers in Endocrinology 12 (2021): http://dx.doi.org/10.3389/fendo.2021.674666. 10.3389/fendo.2021.674666 Lima, Ana Rita; Correia, Marcelo; Santos, Liliana; Tavares, Catarina; Rios, Elisabete; Canberk, Sule; Soares, Paula; et al. "S616-p-DRP1 associates with locally invasive behavior of follicular cell-derived thyroid carcinoma". Endocrine 73 1 (2020): 85-97. http://dx.doi.org/10.1007/s12020-020-02546-4. 10.1007/s12020-020-02546-4 Canberk, Sule; Lima, Ana Rita; Correia, Marcelo; Batista, Rui; Soares, Paula; Máximo, Valdemar; Simões, Manuel Sobrinho. "Oncocytic thyroid neoplasms: from histology to molecular biology". Diagnostic Histopathology 25 5 (2019): 154-165. http://dx.doi.org/10.1016/j.mpdhp.2019.02.002. 10.1016/j.mpdhp.2019.02.002 Lima, Ana Rita; Santos, Liliana; Correia, Marcelo; Soares, Paula; Sobrinho-Simões, Manuel; Melo, Miguel; Máximo, Valdemar. "Dynamin-Related Protein 1 at the Crossroads of Cancer". Genes 9 2 (2018): 115. http://dx.doi.org/10.3390/genes9020115. 10.3390/genes9020115 Sonpavde, Guru; Peters, Solange; Nordquist, Luke T.; Kato, Terufumi; Miranda, Paulo Andre; Wang, Qin; Socinski, Mark A.. "A phase 3b safety study of fixed-dose durvalumab + tremelimumab or durvalumab monotherapy in advanced solid malignancies (STRONG): Urothelial and non-urothelial urinary tract carcinoma module A.". Journal of Clinical Oncology 36 6_suppl (2018): TPS538-TPS538. http://dx.doi.org/10.1200/jco.2018.36.6_suppl.tps538. 10.1200/jco.2018.36.6_suppl.tps538